Abstract:Background/purpose: Results of small bowel transplantation remain unsatisfactory because of severe immune rejection. The current study aims to elucidate the role of activation of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft and, hence, provide the immunologic basis for developing new therapeutic strategies. Methods: We used an MHC fully mismatched (DA to Lewis) heterotopic rat small bowel transplant model and a unique FK506-based immunosuppressive regimen, which suppresses early acute rejection but does not prevent late acute rejection. Flow cytometric analysis was used to quantitate the number of activated CD4+ and CD8+ T cells in graft and host mesenteric lymph nodes. Results: The survival (mean +/- SD) of intestinal allograft was significantly prolonged, from 6.6 +/- 0.84 days for the untreated group to 40.7 +/- 14.1 days for the FK506-treated group. Activation of CD4+ cells was suppressed significantly in the FK506-treated group on postoperative day 7 compared with the untreated group (29.4% +/- 3.55% v 52.83% +/- 11.9%; P <.01). Activation of CD8+ cells was similarly suppressed (31.5 +/- 10.34% v 48.53 +/- 14.34%; P <.05). Interestingly, at late acute rejection, activated CD4+ and CD8+ T cells remained at almost the same low levels as those on postoperative day 7 in the FK506-treated group. The spleen to body weight ratio was significantly increased in the untreated group (0.53 +/- 0.07), and slightly increased in the FK treated group (0.27 +/- 0.07, on postoperative day 7; 0.24 +/- 0.07 at late acute rejection) compared with the syngeneic group (0.18 +/- 0.02). Conclusion: The activation of CD4+ and CD8+ T cells was suppressed effectively by early potent immunosuppressive treatment resulting in prolonged survival of intestinal allograft. At late acute rejection, the CD4+ and CD8+ T cells remained at low-level activation status, in contrast to the surge of CD4+ and CD8+ activation during early acute rejection. This suggests that persistent T cell activation even at low level is sufficient to cause the late acute rejection eventually. A therapeutic strategy targeting these cells is needed for long-term engraftment.

Expression of mucosal addressin cell adhesion molecule-1 during small bowel graft rejection in rat]

Semiquantative analysis of expression of mucosal addressin cell adhesion molecule-1 during small bowel graft rejection in rats

Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1

Relationship Between the Expressions of Intercellular Adhesion Molecule 1, Heat Shock Protein 70 and Acute Rejection after Pancreas Allotransplantation in Miniature Swine

Inflammasome Activation Involved in Early Inflammation Reaction after Liver Transplantation.

[Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule in cardiac allografts and significance thereof: experiment with rats]

Features of chronic allograft rejection on rat small intestine transplantation.

Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft

Sequential Observations Show Upregulation of TGF-β1 at the Early Phase of Chronic Small Bowel Rejection in Rats

Mfn2 Inhibits Chronic Rejection of the Rat Abdominal Aorta by Regulating TGF-β1 Levels.

Increased Apoptosis is Specific for Acute Rejection in Rat Small Bowel Transplant

The Role of CD2 in Acute Rejection after Small Bowel Transplantation in Rats

Formation of Microchimerism in Rat Small Bowel Transplantation by Splenocyte Infusion

Cxcl10 and Cxcl13 Expression Were Highly Up-Regulated in Peripheral Blood Mononuclear Cells in Acute Rejection and Poor Response to Anti-Rejection Therapy

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Impact of antimouse CD52 monoclonal antibody on graft's γδ intraepithelial lymphocytes after orthotopic small bowel transplantation in mice.

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Attenuation of Rat Chronic Small Bowel Allograft Rejection by N‐3 Polyunsaturated Fatty Acids is Associated with Reduced Expression of Graft IL‐15

[The Role of Adhesion Molecules in Rat Liver Allograft Immune Response].

Dietary Omega-3 Polyunsaturated Fatty Acids Can Inhibit Expression of Granzyme B, Perforin, and Cation-Independent Mannose 6-Phosphate/insulin-like Growth Factor Receptor in Rat Model of Small Bowel Transplant Chronic Rejection

Intra Tracheal Instillation of BMSC-cm Attenuate Acute Rejection in Rat Lung Allotransplantation